ACS-Fanconi Discovery Boost Grant
Summary
The ACS and Fanconi Cancer Foundation are offering a two-year Discovery Boost Grant to support high-risk, high-reward translational cancer research focused on people with Fanconi anemia. Projects should advance detection, prevention, or treatment of FA-associated cancers—especially those involving the FA/BRCA DNA repair pathway—through feasibility studies, novel methodologies, or pilot testing. Independent investigators at any career stage can apply for up to $135K per year in direct costs (plus 10% indirect).
Description
Purpose: To fund exploratory research to develop research methodologies, establish feasibility, or pilot test high-risk/high-reward research across the research continuum. RFAs: See the RFA webpage for the scope and intent of the RFA. Applications outside the scope will be withdrawn.
Who Can Apply: Independent investigators at any career stage.
Funding: 2 years with $135K a year direct costs, plus 10% allowable indirect costs
RFA: ACS - Fanconi Cancer Foundation Discovery Boost Grant
Overview of the Opportunity
The American Cancer Society (ACS) and the Fanconi Cancer Foundation (FCF) have partnered to invite proposals for translational cancer research projects that address the unique challenges faced by individuals with Fanconi anemia (FA). FA is a rare inherited disorder caused by mutations in genes critical for DNA repair, including BRCA1 and BRCA2.
This award will support high-risk, high-reward projects with transformative potential—innovative ideas that push the boundaries of current understanding and hold promise for meaningful clinical application. We aim to fund bold translational research that can lead to improved detection, prevention, or treatment of cancers in individuals with FA.
Mark Your Calendar
RFA Release: Sept.2026
Application Deadline: Dec. 1, 2026
Application Review Period: Mar. 2027
Anticipated Notification of Award: Aug. 2027
Anticipated Grant Start Date: Oct. 1, 2027
Scientific Scope
Research must be translational in nature and directly applicable to FA-associated cancers, particularly those influenced by defects in the FA/BRCA DNA repair pathway in people with FA. The proposed project should clearly state how it will advance FA cancer research and lead to clinical benefit for individuals with FA. Applications may come from FA experts or researchers in related cancer biology fields who propose pivoting toward FA-relevant studies. Applications from investigators new to the FA research field should show strong relevance and impact toward the below areas of interest.
Areas of interest include, but are not limited to:
- Early detection technologies and biomarkers for FA-related squamous cell carcinomas
- Mechanisms or interventions to prevent FA-related tumors
- Therapeutic strategies tailored to the FA population’s sensitivity to DNA-damaging agents
- Novel models to study FA tumorigenesis and treatment response
- High-throughput or systems biology approaches to identify FA-specific cancer vulnerabilities
Preference will be given to proposals with a clear translational path for detecting, preventing, or treating cancer in people with FA, including collaborations with clinicians, diagnostic developers, or pharmaceutical partners. New applications and resubmissions of applications previously submitted to this RFA will be accepted.
Eligibility
Typically, you are eligible to submit a proposal if you:
- Work at a US academic institution or eligible non-profit
- Are an independent investigator at any career stage with a full-time faculty appointment (or equivalent)
Applicants are encouraged to review the eligibility criteria in the grant policies document. Applications that do not align with the scientific scope of the RFA will be withdrawn and returned without review.
Term and Budget
Awards are for up to $135,000 direct costs per year for up to 2 years, plus 10% indirect costs. The maximum allowable budget is $297,000 for a 2-year project period.
Inquiries
Program Contact: Doug Hurst, PhD, at doug.hurst@cancer.org
Link to Policies Link to Instructions
About the Fanconi Cancer Foundation
The Fanconi Cancer Foundation (FCF) is the leading global nonprofit dedicated to advancing research, advocacy, and support for people affected by Fanconi anemia (FA) and associated cancers. FCF has funded over $32 million in research worldwide, driving advances in bone marrow transplant, gene therapy, and cancer prevention. Current initiatives include a FA data commons, global research consortia, and a repository of shared research materials. FCF fosters scientific collaboration, community empowerment, and clinical innovation to improve and extend the lives of individuals with FA.
Source
Award
Dates
Eligibility
Program & Phase
Keywords
Supporting Links
Documents
Similar Opportunities
-
RFA: Leukemia Exploration and Prevention Grant Program (LEAP)
American Cancer Society
-
RFA: Yosemite-American Cancer Society Award
American Cancer Society
-
Cancer Health Research Centers (CHERCs)
American Cancer Society
-
Postdoctoral Fellowships (PF)
American Cancer Society
-
Mission Boost Grants (MBG)
American Cancer Society
Find tens of thousands more opportunities — free
Scout accounts are free. Sign up to browse the full funding database, unlock the solicitation links and documents for this opportunity, and see how well each one fits your organization.
-
Tens of thousands of funding opportunities
Search and filter every grant and solicitation in Scout — all free, no credit card required.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Save opportunities & track deadlines
Keep the opportunities that fit in one place and stay ahead of every due date.
Already have an account? Sign In
Trusted by 500+ Happy Customers